Strategic planning for every business leaders requires weighing the pros and cons of any new implementation. One of the metrics measures is the benefit cost ratio (BCR), also known as the cost benefit ...
The Trump Administration’s weakening of regulatory benefit-cost analysis vests unequal power in executive review.
The cost avoidance of heart failure–related hospitalizations and emergency department visits may outweigh the additional drug cost in Medicaid members adherent to sacubitril/valsartan. Objective: To ...
Business leaders use both cost-benefit and breakeven analyses to steer their companies in the right direction and make critical decisions. However, each analysis is used for specific purposes and aids ...
The coronavirus pandemic has forced governments to face excruciating trade-offs. Benefit-cost analysis is a standard framework for making policy trade-offs, and some have suggested that it be used to ...
Objectives: To examine actual use of formal benefit/cost and benefit/risk results in health system decision making by public and private healthcare organizations. Study Design and Methods: A direct ...
The Curry administration’s financial analysis of the Lot J development showed a “project ROI,” or return on investment, of 1.69. This was the ratio of financial incentives for project developers to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback